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Early detection of Johne’s disease (JD) caused by Mycobacterium avium subspecies paratuberculosis (MAP) is essential to
reduce transmission; consequently, new diagnostic techniques and approaches to detect MAP or markers of early MAP
infection are being explored. The objective was to identify biomarkers associated with MAP infection at 6 and 9 months
after oral inoculation. Therefore, gene expression analysis was done using whole blood cells obtained from MAP-infected
calves. All MAP-inoculated calves had a cell-mediated immune response (IFN-γ) to Johnin PPD specific antigens, and
60% had an antibody response to MAP antigens. Gene expression analysis at 6 months after inoculation revealed
downregulation of chemoattractants, namely neutrophil beta-defensin-9 like peptide (BNBD9-Like), S100 calcium
binding protein A9 (s100A9) and G protein coupled receptor 77 (GPR77) or C5a anaphylatoxin chemotactic receptor
(C5a2). Furthermore, BOLA/MHC-1 intracellular antigen presentation gene was downregulated 9 months after inoculation.
In parallel, qPCR experiments to evaluate the robustness of some differentially expressed genes revealed consistent
downregulation of BOLA/MHC-I, BNBD9-Like and upregulation of CD46 at 3, 6, 9, 12, and 15 months after inoculation. In
conclusion, measuring the expression of these genes has potential for implementation in a diagnostic tool for the early
detection of MAP infection.Introduction
Mycobacterium avium subsp. paratuberculosis (MAP)
causes Johne’s disease (JD) in ruminants, characterized
by a chronic granulomatous intestinal infection [1]. In-
fections with MAP are prevalent worldwide in ruminants,
but are also suggested to play a role in Crohn’s disease in
humans [2]. Both are driving the increasing interest in
MAP and JD. The primary route of transmission is fecal-
oral, with infected cattle typically remaining subclinical for
an extended interval [3]. In the end stages of JD, MAP-
infected cows have chronic diarrhoea and emaciation, lead-
ing to early culling. Infection with MAP is estimated to
cost the Canadian dairy industry $15 to 20 M annually [4].
Although MAP was discovered as the causative organ-
ism of JD early in the 19th century, there are still numer-
ous gaps in our knowledge with regard to JD pathogenesis* Correspondence: jdebuck@ucalgary.ca
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are lacking. Existing diagnostic tools and strategies are in-
adequate, due to lack of sensitivity to detect MAP infec-
tion during early subclinical stages [5-8] when diagnostic
test like ELISA and fecal culture fail to detect infection or
have poor sensitivity. Hence, novel biomarkers are consid-
ered as alternatives for early identification of the infection.
Translation genomics and protein arrays have been applied
to identify biomarkers for early detection of JD [9-11]. Po-
tential biomarkers for diagnosis include genes involved in
host stress and immune response to the disease, suggesting
that understanding the pathophysiology of MAP infection
is crucial in identifying specific biomarkers. Moreover, a
practical biomarker needs to be specific, robust and easily
measurable without invasive procedures [10]. In a previous
study, several putative biomarkers of early (3 months after
inoculation) MAP infection were found with particular
roles in the immune response [12]. Furthermore, the im-
portance of dose of infection on the discovery of bio-
markers was also apparent in that study. The objectives oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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biomarkers for MAP infection at 6 and 9 months stage of
inoculation and to confirm the influence of infective dose
on these transcripts. Furthermore, we aimed to analyse ex-
pression levels of select gene targets over a 15 months
period after inoculation to validate their potential use as
early diagnostic biomarkers.
Materials and methods
Animals
Selection, nutrition, health and husbandry of the animals
and the design of the MAP infection experiment have
been reported [12,13]. In short, Holstein-Friesian bull
calves were procured from Alberta (Canada) dairy farms
with zero MAP fecal culture prevalence and a low (< 5%)
MAP sero-prevalence. Five calves were orally inoculated
with a high dose (HD) [14] of MAP, 5 with a low dose
(LD), and another 5 were kept as non-inoculated controls;
the bacteria were a virulent cattle type MAP strain isolated
from a clinical Alberta JD case (Cow 69). This isolate has
an identical BamHI, PvuII and PstI IS900 – RFLP profile
as the reference strain K10 recommended for use in infec-
tion trials [15]. Calves were inoculated at 2 weeks of age
on 2 consecutive days, with either 5 × 109 CFU (HD) or
5 × 107 CFU (LD). The animal care protocols were ap-
proved by the Animal Care Committee of the University
of Calgary (M09083).
MAP exposure assays
Both control and MAP-inoculated calves were tested every
month for exposure to MAP. Humoral response was de-
termined with a commercial antibody ELISA (Pourquier
ELISA™; Institut Pourquier, Montpellier, France) as previ-
ously described in [16] whereas the cell-mediated immune
response used an IFN-γ release assay. For the latter, whole
blood was incubated in a 24-well plate overnight with
Johnin PPD and post-incubation supernatants were used
for BOVIGAM® IFN-γ ELISA (Prionics, Schlieren-Zurich,
Switzerland). Liquid MAP culture (TREK para-JEM®; TREK
Diagnostic Systems, Cleveland, OH, USA) was performed
as described previously in [17] on fecal samples collected
weekly, starting in the first month after inoculation and
thereafter, monthly until necropsy. All calves were eutha-
nized at 17 months of age. Macroscopic and histological
lesions were assessed and bacterial culture was done on nu-
merous tissues [13].
Sample collection and preparation
Every 3 months, whole blood was collected from HD,
LD and control calves in PAXgene® Blood RNA system
tubes (PreAnalytix GmbH, Hombrechtikon, Switzerland).
Total RNA was extracted from whole blood using the
PAXgene® blood miRNA kit (PreAnalytix GmbH) as per
kit protocol. The quality of total RNA was determinedusing an RNA integrity number (Agilent RNA 6000
NanoChip on 2100 Bioanalyzer, Agilent Technologies,
Santa Clara, CA, USA). Moreover, 5–10 μg of extracted
total RNA was processed using RNeasy Plus Micro kit
(Qiagen, Mississauga, ON, Canada) to remove any
genomic DNA carryover. The RNA was quantified
using NanoDrop ND-1000 (NanoDrop Technologies,
Wilmington, DE, USA). Although total RNA was ex-
tracted from whole blood collected from trial calves at
3, 6, 9, 12 and 15 months, only total RNA from 6 and
9 months after MAP exposure was used for gene ex-
pression analysis by microarray.
Hybridization
Biotin-labelled antisense RNA (aRNA) was prepared from
100 ng of genomic DNA purified from total RNA using a
GeneChip® 3’-IVT express kit (Affymetrix, Santa Clara,
CA, USA). Furthermore, 12 μg of biotin-labelled aRNA
was fragmented (35–200 nt) at 95 °C for 35 min for
hybridization. Fragmented biotin-labelled aRNA were hy-
bridized to an Affymetrix® GeneChip® Bovine genome
Array at 45 °C for 16–18 h. Arrays were stained with
streptavidin-phycoerythrin and washed using Affymetrix®
GeneChip Fluidics 450 following manufacturer’s protocol
and scanned with an Affymetrix® GeneChip Scanner 3000
7G System at the Southern Alberta Microarray Facility
(Calgary, AB, Canada).
Gene expression statistical analysis
Gene expression profiles were generated as CEL files using
GeneChip® Command Console® Software (AGCC), with
GeneSpring™ Gx (Agilent Technologies, Santa Clara, CA,
USA) used for statistical analyses. Raw data were normal-
ized and summarized using a robust multichip averaging
(RMA) algorithm and Probe Logarithmic Intensity ERror
(PLIER) algorithm, as reported [12]. Both RMA and PLIER
algorithms employ quantile normalization; the former uses
perfect match (PM) to correct the background fluores-
cence intensity, whereas the latter uses both PM and mis-
match probes from the error correction. Gene transcripts
were filtered based on probe expression levels (default set-
tings for low and high were 20 and 80%, respectively), with
coefficient variation ≤ 50% (part of quality control). In
addition, quality control passed probe sets were analysed
using ANOVA to check for differentially expressed probe
sets among HD, LD and control calves. The Benjamini-
Hochberg FDR correction method was used to obtain reli-
able gene expression data. Finally, 1.5-fold change analysis
was done to determine fold change of differentially
expressed probes. Hierarchical clustering and Principal
Component Analysis (PCA) were performed on the en-
tities designated differentially expressed (by ANOVA)
to determine the significant differential gene expression
profile between analysed groups.
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An additional analysis was performed with ANOVA (p ≤
0.10) on both RMA and PLIER to obtain entities for sys-
tems biology analysis. Ingenuity® Systems Pathway Ana-
lysis (IPA; Ingenuity Systems, Redwood City, CA, USA)
was used to identify biological relevance, annotate and
predict molecular and cellular functions of each gene and
identify their involvement in biological processes. Differ-
entially expressed probesets (based on ANOVA) were sub-
mitted as Affymetrix® GeneChip® Bovine Genome Array
gene set and annotated using bovine genome array data-
bases available on IPA.
Significance of relationship to a functional category or
pathway was assigned by calculating the ratio between
total molecules in that function by the number of mole-
cules from the dataset. Significance was also estimated
by a right-tailed Fisher’s exact test (relationships with
p ≤ 0.05 were considered significant). In addition, Z-scores
were calculated for upstream and downstream analyses
and tested for significance to place differentially expressed
transcripts in the context of functional categories and
pathways.
Reverse transcription for qPCR
Total RNA, extracted from the blood of the calves at
3, 6, 9, 12 and 15 months after infection, was used to
prepare cDNA for qPCR analysis. Reverse Transcription
(RT) reaction was carried out using The Quantitect® Re-
verse transcription kit (Qiagen, Mississauga, ON, Canada).
For this, 1 μg of genomic DNA purified total RNA was
used to prepare cDNA, which involved a genomic DNA
elimination reaction and an RT reaction at 42 °C for 10
and 30 min, respectively. The RT mix included oligo-dT
and random primers and omniscript and sensiscript re-
verse transcriptase enzymes to synthesize cDNA. For the
post RT-reaction, all cDNA samples was diluted to
100 ng/μL and stored at −20 °C to be used for qPCR
validation.
Real-time qPCR
Based on fold change and relevance to the study, 6 genes
from 6 months after infection gene expression data and
5 from 9 month gene expression data were chosen for
qPCR validation. Intron-spanning primers for these genes
were designed using the Primer3 Version 0.4.0 online tool.
Primers were synthesized at University of Calgary DNA
synthesis lab (Calgary, AB, Canada); primer sequences and
information are shown (Tables 1 and 2). Based on previ-
ous publications [18,19] and geNorm analysis done using
qBasePLUS (Biogazalle, Zwijnaarde, Belgium), GAPDH was
used as a reference gene for normalization. For these stud-
ies, 100 ng of cDNA was used for all samples and experi-
ments were done using Qiagen quantitect SYBR green
reagents (Qiagen, Mississauga, ON, Canada) on CFX96™Real-Time PCR detection system. The MIQE guidelines
were adopted for qPCR confirmation assays, as recom-
mended [20]. Prior to gene expression analysis, repeatabil-
ity and efficiency for each primer was analysed using
Bio-Rad CFX Manager™ 2.0 (Bio-Rad, Mississauga, ON,
Canada) as part of the primer standardization procedure.
Pooled RNA samples were used as non-reverse transcrip-
tion (NRT) control to measure genomic DNA carry over.
Real-time PCR amplification in this study involved initial
enzyme activation at 95 °C for 15 min and 45 cycles of
95 °C for 10 s, 15 s at 60 °C, and 15 s at 72 °C extension
step. Melt curve analysis was done at the end of ampli-
fication to ensure product specificity. Cycles of threshold
values obtained by gene expression qPCR assays were
exported in Excel format using Bio-Rad CFX Manager™
2 for statistical analysis. Calculations for gene expres-
sion analysis were done in Excel, using the 2-δδCT
method; log2 fold changes obtained were then analysed
by ANOVA (p ≤ 0.05) with Tukey post hoc tests done
using GraphPad Prism version 5.0c (La Jolla, CA, USA)
for Mac OS X.
Additional qPCR reactions were done on selected
genes (BOLA, CD46 and BNBD9-like) on samples ob-
tained at 3, 6, 9, 12 and 15 months to characterize ex-
pression profiles of these genes over time. Two-way
ANOVA (p ≤ 0.05) was performed on the longitudinal
gene expression analysis to determine statistical sig-
nificance for the expression profiles of these genes.
Results
MAP exposure test results
All MAP-inoculated calves (HD and LD) became and
remained positive for Johnin PPD-specific IFN-γ response
within 3 months after inoculation, whereas all control
calves remained negative for the duration of the study.
All MAP-inoculated calves, except one LD calf, shed
MAP at least once during the 17-month follow-up and
had MAP-positive intestinal tissues at necropsy. Fur-
thermore, MAP was detected in fecal samples from
one control calf by PCR, but no viable MAP was not
cultured.
Control calves remained ELISA-negative, whereas 4
out of 5 (80%) HD MAP-inoculated cattle and 2 out of
5 (40%) LD MAP-inoculated cattle became ELISA-
positive.
Gene expression 6 months after inoculation
Gene expression analysis, using RMA and PLIER algo-
rithm summarized entities, identified 101 transcripts that
were differentially expressed, based on ANOVA using
RMA and 186 transcripts using PLIER algorithm. Like-
wise, 1.5 fold-change analyses revealed 37 transcripts dif-
ferentially expressed in RMA and 21 transcripts using the
PLIER algorithm. In addition, PCA done on transcripts
Table 1 qPCR primers used for 6 month gene targets
Target Primer sequence (5′-3′) Amplicon size Ensembl gene ID
BOLA ACATGGAGCTTGTGGAGACC 283 bp ENSBTAG00000002069
CTTGCAGCCTGGGTGTAGAT
BNBD9-Like TCTTCCTGGTCCTGTCTGCT 106 bp ENSBTAG00000047740
ATCTGTCTCGTGCGTCCAG
ALOX15 CCACCAAGGATGTGACACTG 251 bp ENSBTAG00000011990
GTATTCGTAGGGCCAGTCCA
ALOX5AP TTCTCTGCAGCCAAGTTCCT 251 bp ENSBTAG00000013201
GAGAAGGAGAGGGGAGATGG
S100A9 GTCACAAATGGAAAGCAGCA 238 bp ENSBTAG00000006505
GGCCACCAGCATAATGAACT
GPR77 CCGAAACTGTGCACTCAAGA 222 bp ENSBTAG00000037735
GCCGAGAGAATTGTTCTCCA
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samples into HD, LD and control groups (Figure 1A and B).
In the overall gene expression profile, both HD and LD
calves had 60% of their differentially expressed genes
upregulated compared to the control. Furthermore, HD
and LD calves had opposite expression profiles for 50%
of their differentially expressed genes. Using hierarchical
clustering on MAP exposure (HD, LD and control), control
calves clustered in a separate branch from HD and LD with
a centroid Euclidean distance of 0.32. HD and LD calves
clustered as sub clusters under a same branch with a cen-
troid Euclidean distance of 0.17 from each other. Additional
ANOVA analysis with p ≤ 0.10 on both RMA and PLIER
summarized entities resulted in 1702 entities for sys-
tems biology analysis. A complete list of the differen-
tially expressed genes is included (Additional file 1).
Arachidonate 15-lipoxygenase (ALOX15), Arachidonate
5-lipoxygenase activating protein (ALOX5AP), neutrophil
beta-defensin-9 like peptide (BNBD9-Like), S100 calcium
binding protein A9 (s100A9) and G protein coupled
receptor 77 (GPR77) or C5a anaphylatoxin chemotacticTable 2 qPCR primers used for 9 month gene targets
Target Primer sequence (5′-3′)
BOLA GAACTACCTGGAGGGCGAGT
GGTTTCCACAAGCTCCATGT
CCR7 CCCTTCTCGTCATTTTCCAG
GGAGTACATGATCGGGAGGA
IGSF6 TTTCCCAACTCAAAGCAACC
TACGCCGAGCACTCTTTTTC
IL4R GTGTGCGTGTCCTGCTACAT
GTAAACAGGGCAGGAGCTTG
TEX261 CACCTACATGATTGGCGTTG
GAAGAACGCAAACGGGATTAreceptor C5a2 were downregulated in both HD and LD
calves (Table 3).
Systems biology analyses for genes differentially
expressed at 6 months after inoculation
Of the 1702 entities submitted to IPA, 1066 were used
for systems biology analyses. Downstream function ana-
lysis revealed activation of lymphocyte movement and
its migration, migration of mononuclear leukocytes and
intracellular infection of the cells. In addition, IPA pre-
dicted inhibition of phagocytosis by antigen presenting
cells, phagocytosis by macrophages, migration of granu-
locytes, immune response by macrophages, necrosis, apop-
tosis and downregulation of genes that would inhibit
growth. All these predictions had a significant Z-score
(either ≥ 2 signifying activation or ≤ −2 indicating downreg-
ulation). Pathway analysis indicated that the differen-
tially expressed genes had roles in several biological
pathways; the top 5 canonical pathways included the
superpathway of Inositol phosphate compounds, D-
myo-inositol (1,4,5,6)-Tetrakisphosphate biosynthesis,Amplicon size NCBI Accession number
229 bp ENSBTAG00000019386
158 bp ENSBTAG00000015133
238 bp ENSBTAG00000018869
202 bp ENSBTAG00000001602
226 bp ENSBTAG00000002105
Figure 1 Principle Component Analysis on entities differentially expressed. Differentially expressed entitites between treatment groups
were identified using ANOVA (p≤ 0.05) at 6 months (A-B) and 9 months (C-D) after inoculation using RMA or PLIER algorithms respectively. A
distribution for all 16 animals obtained using three principal components is shown in a 3D space. At 6 months, the percent variances of the three
components by RMA were 54.88, 11.69 and 6.5%, and by PLIER 59.01, 10.01 and 4.17%. At 9 months, the percent variances of the three components
were by RMA were 46.83, 14.94 and 5.52%, by PLIER 50.72, 16.0 and 5.99%.
David et al. Veterinary Research 2014, 45:96 Page 5 of 12
http://www.veterinaryresearch.org/content/45/1/96D-myo-inositol (3,4,5,6)-Tetrakisphosphate biosynthesis,
D-myo-inositol-5-phosphate metabolism and 3-phosphoi-
nositide degradation. JAK-STAT signalling pathway, a key
regulator of immune response, was among the top canon-
ical pathways (14th rank). The complete list of the canonical
pathways influenced by our differentially expressed genes
is shown (Additional file 2).
Upstream analysis predicted activation of CD40 ligand
(CD40L), CD24, matrix metallopeptidase 14 (membrane-
inserted) (MMP14) and TNF family proteins. Transform-
ing growth factor beta 1 (TGF-beta1), several micro RNA’s
(miRNA) were predicted to be inhibited based on expres-
sion levels of molecules differentially expressed amongthe 3 groups. A list of all the upstream regulators and
their direction of activation along with Z-score is shown
(Additional file 3).
Gene expression 9 months after inoculation
Analysis of gene expression using RMA identified 31 and
12 transcripts (based on ANOVA and 1.5 fold-change ana-
lyses, respectively). Furthermore, ANOVA and 1.5 fold-
change analyses using PLIER algorithm detected 49 and
3 transcripts, respectively, that were differentially expressed.
Furthermore, PCA analysis on entities differentially
expressed by ANOVA (p ≤ 0.05) resulted in clear separ-
ation of HD, LD and control groups (Figure 1C and D). In
Table 3 Fold change comparison between microarray and real-time qPCR for all gene targets between HD, LD and
control groups at 6 month after MAP infection
Microarray fold change Real-time qPCR fold change
Gene High vs. control Low vs. control High vs. low High vs. control p-value Low vs. control p-value High vs. low p-value
BOLA 0.83 0.88 0.94 0.18 < 0.001 0.58 < 0.01 0.32 < 0.01
BNBD9-Like 0.69 0.63 1.01 0.56 < 0.01 0.19 < 0.001 0.33 < 0.01
ALOX5AP 0.54 0.68 0.81 0.58 < 0.01 1.56 < 0.01 0.38 < 0.01
ALOX15 0.35 0.83 0.42 0.35 < 0.01 0.74 < 0.05 0.48 < 0.01
GPR77 0.68 0.66 1.02 0.58 < 0.05 0.56 < 0.05 0.91 NS
S100A9 0.64 0.64 0.99 0.39 < 0.05 0.61 < 0.05 0.64 < 0.05
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their transcripts upregulated compared to control calves,
whereas the LD group had 86% of transcripts upregu-
lated compared to controls. Hierarchical clustering on
conditions (HD, LD and control groups) of differentially
expressed entities had HD calves clustered in a separate
branch from control and LD groups (centroid Euclidean
distance of 0.25). Control and LD calves were subclusters
under the same branch (centroid Euclidean distance of
0.20). Additional ANOVA analysis with p ≤ 0.10 per-
formed on both RMA and PLIER algorithm summarized
entities resulted in 408 differentially expressed transcripts
which were used for systems biology analyses. A complete
list of differentially expressed transcripts with their fold-
changes is shown (Additional file 4).
Nine months after inoculation, bovine leukocyte antigen
(BOLA), interleukin 4 receptor (IL4R), chemokine (C-C
motif ) receptor 7 and testis expressed 261 (TEX261)
genes were downregulated in HD and LD calves. Im-
munoglobulin super family member 6 (IGSF6), ribosomal
protein L15 (RPL15) were upregulated in both LD and
HD calves.
Systems biology analyses for genes differentially
expressed at 9 months after inoculation
Of the 408 entities submitted to IPA, 275 entities were
used for systems biology analyses. Downstream function
analysis predicted differentially expressed transcripts to
activate autophagy, activation of antigen presenting cells,
cytotoxicity of T-lymphocytes, and organisation of the cyto-
plasm for cell replication. Downstream analysis also pre-
dicted inhibition of apoptosis, generation of T-lymphocytes
and cell spreading. However, these functions lacked signifi-
cant Z-scores.
The top 5 canonical pathways included acute myeloid
leukaemia signalling, methionine degradation I (to homo-
cysteine), cysteine biosynthesis III (Mammalia), ERK5 signal-
ling and Neurotrophin/TRK signalling. The IL-4 signalling
pathway, involved in Th2 response, was the 9th canonical
pathway. A complete list of all canonical pathways in which
differentially expressed genes were predicted to be involvedis shown (Additional file 5). Upstream analysis predicted
inhibition of several miRNAs, hypoxia inducible factor
1, alpha subunit (HIF1A), chemokine (C-X-C motif ) lig-
and 12, forkhead box O3 (FOXO3) and myelocytomatosis
viral oncogene homolog (Avian) (MYC) and predicted
few miRNAs to be activated. A list including complete
upstream analysis results is shown (Additional file 6).Overlap of affected pathways at 3, 6 and 9 months after
inoculation
Differentially expressed genes were found in a total of 476
canonical pathways, at either 3 [12], 6 and 9 months after
inoculation, with 55%, 73% and 56% of these pathways af-
fected at the respective time points. A total of 89 (19%) of
these pathways were affected at every of the three time
points, and 36%, 43% and 24% overlapped at respectively 3
and 6, 6 and 9 and 3 and 9 months after inoculation. At
those respective times, only 24%, 17% and 12% of the
pathways were unique to these time points.Real-time qPCR confirmation microarray data
To validate microarray findings, 6 gene targets from the
6 months after inoculation gene expression data and 5 gene
targets from 9 months after inoculation gene expression
data were chosen to be verified using real-time qPCR. Genes
for qPCR validation were chosen based on the relevance of
the transcripts to JD and their fold change. Genes selected
to confirm gene expression data at 6 months after in-
oculation were BOLA, BNBD9-Like, ALOX-15, ALOX5AP,
GPR77 and s100A9. Similarly, genes selected for qPCR
confirmation of gene expression data at 9 months after in-
oculation were BOLA, TEX261, CCR7, IL4R and IGSF6.
Quantitative gene expression data obtained for these genes
using qPCR was in agreement with microarray data. Real-
time qPCR confirmation of the differentially expressed
genes at 6 and 9 months after MAP inoculation are shown
(Figures 2 and 3, respectively). A comparison of microarray
expression data and qPCR expression data for the con-
firmed genes obtained 6 and 9 months after MAP inocula-
tion are presented (Tables 3 and 4).
Figure 2 qPCR validation of gene expression data at 6 month after inoculation. The bar diagram shows the comparison of fold changes
(Y axis) of high and low dose groups compared to control group for each of the gene targets (X axis). ANOVA with Tukey post-hoc test was used
for this analysis, with ** indicating significant difference with p≤ 0.01 and *** indicating significant differences with p≤ 0.001.
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BNBD9-Like genes
Based on the gene expression studies by microarray ana-
lysis at 3, 6 and 9 months after MAP inoculation, CD46,
BOLA and BNBD9-Like were differentially expressed at
all 3 measured time points. Longitudinal expression pro-
filing of these genes at 3, 6, 9, 12 and 15 months after
MAP inoculation by qPCR, demonstrated that CD46
was continuously upregulated in both HD and LD calves
from 3 to 15 months after MAP inoculation onwards, ex-
cept for 3 months after MAP inoculation for LD calves.
Both BOLA and BNBD9-Like genes were downregulated
in MAP-inoculated calves (HD and LD) at time points 3
to 15 months after inoculation. Two-way ANOVA doneFigure 3 qPCR validation of gene expression data at 9 month
after inoculation. The bar diagram shows the comparison of fold
changes (Y axis) of high and low dose groups compared to control
group for each of the gene targets (X axis). ANOVA with Tukey post-hoc
test was used for this analysis, with ** indicating significant difference
with p≤ 0.01 and *** indicating significant differences with p≤ 0.001.on the longitudinal expression values for all 3 genes re-
vealed significant differences (p ≤ 0.01). The relative
expression of CD46, BOLA and BNBD9-Like genes
across time are shown in Figure 4.
Discussion
Inoculation with MAP (HD or LD) resulted in a chronic
infection in all calves, confirmed by fecal shedding, anti-
body ELISA [16] and positive culture of intestinal tissues
[17]. However, one LD calf merely had a repeated posi-
tive interferon-gamma test as an indication of exposure
to MAP.
Early diagnosis of MAP, similar to diagnosis of Mycobac-
terium tuberculosis, is challenging and largely dependent on
detection of cellular immune responses, due to low sensitiv-
ity for other tests [21,22] at this stage of infection. Regard-
less, detection of cellular immune responses is undermined
by test complexity and specificity, especially during the early
stages of the disease [8,23,24]. Hence, new biomarkers for
early diagnosis of Mycobacterial infections are needed.
Unlike previous studies, the current study focused on
identifying biomarkers for JD from differentially expressed
transcripts in whole blood of HD and LD MAP-inoculated
calves at 6 and 9 months after inoculation with MAP.
In this study, key inflammation and immune-related
genes (ALOX15, ALOX5AP, BNBD9-Like, GPR77, and
S100A9) were downregulated 6 months after inoculation.
ALOX15 belongs to lipoxygenases (LOXs) involved in me-
tabolism and production of fatty acid hydroperoxidases [25].
ALOX5AP along with ALOX5 has a role in leukotriene
biosynthesis, which is implicated in various inflamma-
tory responses [26]. Enzyme 12/15-LOX or 15-LOX1 is
activated by IL-4 in Th2 type response in monocytes
and macrophages [27]; it has a role in resolution of in-
flammation [28,29] and synthesis of lipoxins, which also
Table 4 Table illustrating the fold change comparison between microarray and real-time qPCR for all gene targets
between HD, LD and control groups at 9 months post MAP-infection
Microarray fold change Real-time qPCR fold change
Gene High vs. control Low vs. control High vs. low High vs. control p-value Low vs. control p-value High vs. low p-value
IL4R 0.88 0.93 0.95 0.21 < 0.01 0.48 < 0.01 0.46 < 0.05
CCR7 0.81 1.01 0.73 0.72 < 0.05 0.49 < 0.05 0.67 < 0.05
IGSF6 1.88 1.23 1.53 3.02 < 0.01 2.72 < 0.01 1.37 < 0.01
BOLA 0.38 0.41 1.08 0.22 < 0.01 0.47 < 0.05 0.45 < 0.05
TEX261 0.74 0.81 0.90 0.71 < 0.01 0.39 < 0.01 1.52 < 0.05
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sion and superoxide generation [30]. Down-regulation
of ALOX15 and ALOX5AP in the early stages of MAP
infection correspond to the expected Th1 response-driven
IFN-γ production that inhibits expression of LOXs genes.
Proteins BNBD9-Like and GPR77 act as chemoattractants
to immature dendritic cells [31,32], which function as
professional antigen-presenting cells. S100A9 is a pro-
inflammatory damage-associated molecular pattern (DAMPs)
molecule secreted by phagocytes, granulocytes, mono-
cytes and early differentiation stage macrophages. DAMPs
are recognized by Toll-like receptors (TLRs), leading to
their activation, which results in inflammation [33].
Down-regulation of these inflammatory and immune-
related genes was consistent with a reduced capacity for
an appropriate inflammatory response in MAP-infected
animals.
Canonical pathway analysis revealed alterations in
phosphoinositol biosynthesis and metabolism, and the
JAK-STAT signalling pathway. Phosphatidylinositol signal-
ling pathways are of interest in MAP infection, since these
lipids act as chemoattractants and mediate immune cell
migration [34]. Furthermore, Mycobacterium spp. is known
to control host lipid metabolism to establish an infection
[35]. Many genes involved in phosphatidylinositol sig-
nalling pathways were downregulated in this study.
Conversely, the JAK-STAT pathway is the main signal-
ling cascade involved in activation and regulation of host
immune response following activation by cytokines andFigure 4 Longitudinal expression profiles of CD46, BOLA, BNBD9. The
and low dose groups compared to control group for each time point (X ax
this analysis.growth factors [36]. In this study, there were activation of
STAT proteins and downregulation of other JAK-STAT as-
sociation pathways such as Ras and MEK 1/2. Moreover,
the negative regulator of the JAK-STAT pathway suppres-
sors of cytokine signalling (SOCS) was upregulated and
protein inhibitor of activated STATs (PIAS) was downreg-
ulated. The phosphoinositide 3-kinase (PI3K) pathway was
also activated, leading to m-TOR mediated activation of
STAT3. Therefore, we concluded that the overall JAK-
STAT pathway was activated in MAP-inoculated calves
6 months after inoculation.
Lymphocyte and leukocyte migration were activated in
the downstream pathway analysis. There was upregulation
of chemokine (C-X-C motif) ligand 10 (CXCL10), SH2
domain containing 1A (SH2D1A), TXK tyrosine kinase
(TXK); they enable lymphocyte activation and migration
[37-39]. The latter was consistent with the expected move-
ment of leukocyte and MAP antigen-activated lympho-
cytes to the site of inflammation or infection.
At 6 months after inoculation, key immune functions
such as macrophage response and phagocytosis migra-
tion of granulocytes and phagocytosis by other antigen
presenting cells were downregulated. This was in agree-
ment with MAP-induced inhibition of macrophage mat-
uration described in other studies [14,40]. Necrosis and
apoptosis of cells were concurrently inhibited, as re-
ported at 3 months after inoculation [12] and also in
other studies [41-43] as a virulence mechanism of MAP
to subvert immune detection and immune escape.bar diagram shows the comparison of fold changes (Y axis) of high
is). Two-way ANOVA with Bonferroni post-hoc test was used for
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were downregulated, as reported 3 month after MAP in-
oculation [12]. This suggests a response counteracting mal-
absorption, due to early host immune response and
inflammation which manifested as histological and gross
pathological lesions in MAP-infected tissues [13], as a
homeostatic mechanism to support growth of the animal.
CD40L was activated based on upstream analysis done
using differentially expressed transcripts (6 months after
inoculation) between HD, LD and control. CD40L is
expressed on CD4+ T cells; it interacts with CD40 on the
B cells, and activates them to produce a B cell response,
immunoglobulin class switch and activation of macro-
phages to produce IFN-γ [44]. It is noteworthy that 3 of
the 5 HD animals in this study had seroconverted 6 months
after inoculation. Based on upstream analysis, TGF-beta1
and miRNAs like let-7a-5p and miR-16-5p were suggested
to be inhibited at 6 months after inoculation. TGF-beta1 is
an anti-inflammatory, pro-fibrotic and macrophage de-
activating cytokine, implicated in the pathogenesis of
many intracellular pathogens [45,46]. Mycobacterium
avium complex (MAC) pathogens induce many cytokines,
especially TGF-beta1 [47,48]. TGF-beta1 has an important
role in granulomatous infection; its levels are related to
intracellular replication of MAC [49]. Future studies ana-
lysing TGF-beta1 in subclinical and clinical animals might
help to validate it as biomarker for MAP diagnosis and to
understand its role in immunopathogenesis.
Micro RNAs regulate expression of many genes by post-
translation modification of mRNAs and are associated with
cancer and infectious disease [50-52]. In Crohn’s disease
(CD) patients, several miRNAs (e.g.miR-16 and miR-23b)
were associated with active and chronically active CD pa-
tients [53,54]. In the current study, miR-2277-3p was acti-
vated, whereas several other miRNAs were inhibited. The
exact role of these miRNAs is not known, but they have
potential as markers for JD.
At 9 months after inoculation, gene expression of genes
was generally repressed; based on ANOVA, there were only
80 transcripts differentially expressed among HD, LD and
control calves (p < 0.05). Similarly, in previous translational
studies [55,56] on gene expression in macrophages and
PBMC’s infected with MAP, the number of differentially
expressed genes decreased with time after inoculation.
BOLA/MHC-1 was downregulated 9 months after in-
oculation, in agreement with a previous study [57]. BOLA
is a key antigen-presenting protein that carries intracellu-
lar proteins to the cell membrane and presents it to cyto-
toxic T cells for detection and eventual control or killing
of intracellular pathogens. In addition, IL4R and CCR7
were also downregulated. IL4R and CCR7 belong to G-
protein coupled receptors present on B and T lympho-
cytes and leukocytes, enabling these cells to move to sites
of inflammation and secondary lymphoid organs [58,59].Autophagy, antigen presenting cells, cytotoxicity of T-
lymphocytes and organisation of the cytoplasm for cell
replication were all activated 9 months after inoculation.
The role of autophagy in Mycobacterial infections has
been reported [55,60]; furthermore, we reported that au-
tophagy was already activated 3 months after inoculation
[12]. Perhaps autophagy acts as a compensatory mech-
anism to present intracellular MAP antigens in the con-
text of reduced antigen presentation by MHC-1/BOLA.
Canonical pathway analysis revealed differentially
expressed genes in MAP-infected calves to be involved in
IL-4 signalling pathway. IL-4 is a multifunctional cytokine
produced by CD4+ Th2 cells, basophils and mast cells. In
this study, there was upregulation of son of sevenless
(SOS), 1-phosphotidylionositol 3-phosphate, P70 S6 kinase
(P70S6K) and nuclear factor of activated T cells (NFAT)
belonging to alternate IL-4 signalling pathway. However,
IL-4R in the classical IL-4 signalling pathway was downreg-
ulated. IL-4 is important for granuloma formation in
Mycobacterial infection and defense against Mycobacterial
infection [61]. At 9 months after inoculation, not many
genes were differentially expressed; consequently, upstream
analysis did not lead to many predictions. Activation of
miR-22-3p, miR-4283, miR-320b, miR-3175 and few other
miRNAs are listed in Additional file 6, according to up-
stream analysis at 9 months after inoculation.
BOLA and BNBD9-Like genes were downregulated
and CD46 gene was upregulated in both LD and HD
calves for the duration of the trial (3 to 15 months after
inoculation). Identification of genes that are consistently
differentially expressed genes warrants a larger cohort
study to validate these genes as potential biomarkers for
MAP infection. In this study, BNBD9-LIKE and BOLA
genes were differentially expressed 6 and 9 months after
inoculation. The ubiquitously expressed transmembrane
glycoprotein CD46 was upregulated 3 months after
inoculation [12]. It prevents unwanted complement-
mediated killing of cells by acting as a cofactor in factor-I
mediated degradation of C3b and C4b opsonins [62].
Although CD46 has a regulatory role in Th1 responses
[63,64], it also interacts with STE20/SPS1-related pro-
line/alanine-rich kinase (SPAK) kinase and E-cadherin,
which have important role sin maintaining epithelial
barrier function in intestinal epithelial cells [65].
A large proportion of pathways, including immune and
inflammation pathways, were consistently affected at 3, 6
and 9 months after inoculation, with relatively few path-
ways being affected at only a single time point. However,
no obvious evolution was noticed in the affected pathways
over the course of this follow-up.
In conclusion, many genes were differentially expressed
between MAP-infected animals and control animals at 6
and 9 months after inoculation. BOLA, BNBD9-Like and
CD46 were differentially expressed in both LD and HD
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15 months after inoculation. Dose of infection had an
influence on the fold change of differentially expressed
genes. Migration and trafficking of leukocytes and lym-
phocytes were activated, but there was more downregula-
tion of immune response by inhibition of phagocytosis,
downregulation of antigen presentation, macrophage
phagocytosis and response. Furthermore, MHC-1/BOLA
was downregulated and autophagy was activated, poten-
tially compensating for any loss in antigen presentation
by PRRs on the account of downregulation of MHC-1/
BOLA. Finally, we propose that CD46, BNBD9-Like and
BOLA are further considered as potential biomarkers for
diagnosis of JD.
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